Liu Lunxu

Recombinant Super-Compound Interferon (rSIFN-co) Versus Interferon Alfa in the Treatment of Moderate-to-Severe COVID-19: A Multicentre, Randomised, Phase 2 Trial

Zheng-Yang Shi, N. Xiong, F. Luo, 2020 .

Engineered interferon alpha effectively improves clinical outcomes of COVID-19 patients

Dan Liu, Zheng-Yang Shi, N. Xiong, 2020 .